isomethyleugenol and Bone Loss, Perimenopausal
isomethyleugenol has been researched along with Bone Loss, Perimenopausal in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Li, G; Shan, Y; Shen, G; Wang, L; Xu, Y; Zhang, P | 1 |
Emery, R; Hodges, SJ; Oguz, C; Pitsillides, AA; Soper, RJ | 1 |
Berg, JP; Collas, P; Datta, H; Estrada, K; Gautvik, KM; Gautvik, VT; Grimholt, RM; Halldórsson, BV; Hofman, A; Lyle, R; Medina-Gomez, C; Noer, A; Olstad, OK; Reppe, S; Rivadeneira, F; Uitterlinden, AG | 1 |
Other Studies
3 other study(ies) available for isomethyleugenol and Bone Loss, Perimenopausal
Article | Year |
---|---|
Methylation of bone
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Bone and Bones; Bone Morphogenetic Proteins; Cell Line, Tumor; Cell Proliferation; Core Binding Factor Alpha 1 Subunit; Decitabine; Estrogen Receptor alpha; Genetic Markers; Humans; Methylation; Osteoporosis, Postmenopausal; Sp7 Transcription Factor | 2019 |
Vitamin K catabolite inhibition of ovariectomy-induced bone loss: structure-activity relationship considerations.
Topics: Animals; Bone Density Conservation Agents; Carboxylic Acids; Cell Line; Cell Proliferation; Denervation; Disease Models, Animal; Female; Humans; Injections, Intraperitoneal; Interleukin-6; Methylation; Mice, Inbred C57BL; Molecular Structure; Naphthoquinones; Osteoblasts; Osteoporosis, Postmenopausal; Ovariectomy; Random Allocation; Sciatic Nerve; Structure-Activity Relationship; Vitamin K | 2014 |
Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Topics: Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Bone Density; Bone Morphogenetic Proteins; Demography; Female; Fractures, Bone; Genetic Markers; Humans; Methylation; Middle Aged; Osteoporosis, Postmenopausal; Polymorphism, Single Nucleotide; Postmenopause; Risk Factors; RNA, Messenger | 2015 |